Presidential transitions can be a bit of a roller-coaster ride, with new Cabinet heads often reversing previous policies or creating new ones. However, when it comes to the fight against health-care fraud, the incoming Trump administration is likely to maintain the status quo, a number of former Department of Justice officials told me recently.
Initiatives against health-care fraud are generally supported by Republicans and Democrats, Gejaa Gobena, a health-care attorney with Hogan Lovells in Washington, told me. Gobena, a former deputy chief of the fraud section in the DOJ's criminal division, worked in the administrations of both George W. Bush and Barack Obama. He said he expects the commitment to fighting fraud will continue in the Trump administration.
However, Gobena said if the DOJ prioritizes other areas, such as national security, anti-fraud efforts could lose some resources. Gobena said he expects Sessions will evaluate the DOJ’s approach to health-care fraud and ensure that all resources are being used effectively.
I also spoke with Kirk Ogrosky, a health-care attorney with Arnold & Porter in Washington and former deputy chief of the DOJ’s fraud section, who told me no one wants to be seen as being soft on fraud. While Ogrosky said he expects anti-fraud efforts to be largely the same in a Sessions-led DOJ, he said funding issues could affect enforcement.
Recent funding provisions have expanded the number of agents and prosecutors working health-care fraud cases, and if those funds are cut, the level of enforcement would drop, Ogrosky said.
Gobena told me that recent funding increases for anti-fraud efforts have come through bipartisan spending bills, and he said any future funding increases or decreases will depend on the Trump administration’s views and its relationship with Congress.
Stay on top of new developments in health law and regulation with a free trial to the Health Law Resource Center.
Learn more about Bloomberg Law and sign up for a free trial.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)